CZ ATC M01AC06 · updated 2 Nov 2026
Meloxicam shortage in Czechia
Is there a Meloxicam shortage in Czechia?
Yes. As of 2 Nov 2026, 6 Meloxicam products are reported short in Czechia, the first since 16 Feb 2026. The company estimate for the return is 4 Jan 2027 (latest 30 Apr 2027). Main reason: manufacturing problem.
Also short in Canada, Italy. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | MELOXICAM TEVA 15MG 15MG TBL NOB 100 I | Teva Pharmaceuticals CR, s.r.o., Praha | 16 Feb 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | MELOXICAM TEVA 15MG 15MG TBL NOB 30 I | Teva Pharmaceuticals CR, s.r.o., Praha | 23 Feb 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | MELOXICAM TEVA 15MG 15MG TBL NOB 50 I | Teva Pharmaceuticals CR, s.r.o., Praha | 6 Jun 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | MELOXICAM TEVA 15MG 15MG TBL NOB 20 I | Teva Pharmaceuticals CR, s.r.o., Praha | 8 Jul 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | RECOXA 15MG 15MG TBL NOB 30 | Zentiva, k.s., Praha | 2 Nov 2026 | 4 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | MELOXICAM TEVA 15MG 15MG TBL NOB 10 I anticipated | Teva Pharmaceuticals CR, s.r.o., Praha | 29 Nov 2026 | 30 Apr 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.